These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 810615

  • 1. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance-- (report 1) (author's transl)].
    Baba H, Azuma Y.
    Kekkaku; 1975 Jul; 50(7):191-7. PubMed ID: 810615
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison between SM daily and twice weekly treatment in the regimen of SM, INH and PAS--particularly considering the degree of drug resistance (Report 2) (author's transl)].
    Baba H, Azuma Y.
    Kekkaku; 1977 Dec; 52(12):619-26. PubMed ID: 604603
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of initial combined chemotherapy with SM, INH and EB for pulmonary tuberculosis. 2. Comparison of SM, EB and INH regimen with that of SM, PAS and INH for experimental tuberculosis of mice].
    Makiyama H.
    Kekkaku; 1971 Aug; 46(8):303-8. PubMed ID: 5570128
    [No Abstract] [Full Text] [Related]

  • 5. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract] [Full Text] [Related]

  • 6. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of high dose INH twice weekly regimen in the original treatment for moderately advanced pulmonary tuberculosis. A report of the 12th series B study of the controlled trials].
    Kekkaku; 1972 Jun; 47(6):159-66. PubMed ID: 4562924
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE.
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S, Grella G.
    Rass Int Clin Ter; 1966 Dec 15; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.